SPRO Stock Slides 4.1% as Biopharma Sector Faces Volatility: Market Update
SPRO slides 4% lower amid biopharma volatility, 13.97% drop in 30 days; compare with peer stocks, market cap $71.1 M, 58.2 M shares, all‑time high $3.08.
- SPERO THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read
